Zurück zu Projekte

11667.1;4 PFLS-LS

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Zusammenfassung

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Weitere Texte

Abstract

Non-invasive, nuclear imaging techniques such as positron emission tomography (PET) are crucial for cancer diagnosis, treatment planning and monitoring. The folate receptor (FR) is a promising cancer-related target because it is overexpressed in a wide variety of tumor types. We will develop the first clinically useful PET-folate tracer, which is expected to be of major clinical and health economical relevance as it serves not only for diagnostic purposes but also for identification of patients, who profit from FR-targeting therapies.

Beteiligte

Roger Schibli

Kontaktperson

roger.schibli@pharma.ethz.ch

ETH Zürich Roger Schibli Wolfgang-Pauli-Strasse 10 Institute of Pharmaceutical Science 8093 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2010-10-31
Enddatum
2013-01-07
Bewilligte Gesamtkosten
CHF 125400.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%